The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and pharmacokinetic analysis of UGT1A1 genotype-guided dosing of irinotecan.
 
Emma C. Hulshof
No Relationships to Disclose
 
Mirjam de With
No Relationships to Disclose
 
Femke M. de Man
No Relationships to Disclose
 
Geert-Jan Creemers
No Relationships to Disclose
 
Birgit ALM Deiman
No Relationships to Disclose
 
Jesse J. Swen
No Relationships to Disclose
 
Saskia Houterman
No Relationships to Disclose
 
Stijn L.W. Koolen
Speakers' Bureau - Pfizer
Research Funding - Cristal Therapeutics (Inst); Novartis (Inst); Pfizer (Inst)
 
Marjan Laven
No Relationships to Disclose
 
Saskia Luelmo
No Relationships to Disclose
 
Ron H.N. van Schaik
No Relationships to Disclose
 
Henk-jan Guchelaar
No Relationships to Disclose
 
Ron H.J. Mathijssen
Stock and Other Ownership Interests - Galapagos NV
Research Funding - Bayer Holding (Inst); Boehringer Ingelheim (Inst); Cristal Therapeutics (Inst); Pamgene (Inst); Pfizer (Inst); Roche (Inst)
 
Hans Gelderblom
Research Funding - Daiichi (Inst); Deciphera (Inst); Ipsen (Inst); Novartis (Inst)
 
Maarten J. Deenen
No Relationships to Disclose